Last reviewed · How we verify

NCT07379619: TRIPS

Safe Transport Algorithm and TRIPS in Neonatal Transport

Completed NA Last updated 30 January 2026
What this trial tests

NA trial testing As part of the intervention, a 10-step safe transport algorithm developed by researchers and validated by expert opinion, along with TRIPS, was displayed in clinical areas, and verbal training was pro in Neonatal Nursing in 100 participants. Completed in 8 February 2024.

Timeline
1 June 2022
Primary endpoint
1 April 2023
8 February 2024

Quick facts

Lead sponsorBeste Ozguven Oztornaci
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposebasic science
Enrollment100
Start date1 June 2022
Primary completion1 April 2023
Estimated completion8 February 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Beste Ozguven Oztornaci

Who can join

18 and older, any sex, with Neonatal Nursing or Transportation of Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aim: Newborn babies may need to be referred to different centers to receive the care they need. It is important to improve the quality of neonatal transport to reduce infant mortality rates. This study was conducted to examine the effect of the use of transport algorithm and TRIPS (Transport Risk Index of Physiological Stability) on the knowledge level of nurses and physicians working in the neonatal intensive care unit.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07379619.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing